mesalamine has been researched along with oxazolone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ekström, GM | 1 |
| Hatakeyama, S; Kojima, R; Kuroda, S; Nakamaru, K; Ohkishi, T | 1 |
| Cui, YL; Ding, TT; Yang, X; Zhang, HQ; Zhang, HX; Zhang, JJ; Zhao, JS | 1 |
| Li, YS; Tao, YW; Wang, H; Zhang, JY; Zhang, ZQ; Zhou, Y | 1 |
| Chen, M; Chen, W; Huang, ZH; Ouyang, Q; Xue, LY; Yu, LM; Zhou, XG | 1 |
| Abu-Risha, SE; El-Kadem, AH; El-Mahdy, NA; El-Sayad, ME | 1 |
| Caviglia, GP; Ribaldone, DG; Vernero, M | 1 |
7 other study(ies) available for mesalamine and oxazolone
| Article | Year |
|---|---|
Oxazolone-induced colitis in rats: effects of budesonide, cyclosporin A, and 5-aminosalicylic acid.
Topics: Animals; Budesonide; Colitis; Colon; Cyclosporine; Disease Models, Animal; Female; Intestinal Mucosa; Mesalamine; Organ Size; Oxazolone; Peroxidase; Rats; Time Factors | 1998 |
Oxazolone-induced colitis in BALB/C mice: a new method to evaluate the efficacy of therapeutic agents for ulcerative colitis.
Topics: Animals; Colitis; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Male; Mesalamine; Mice; Mice, Inbred BALB C; Oxazolone; Prednisolone | 2004 |
Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Butyrates; Calcitonin Gene-Related Peptide; Clostridium butyricum; Colitis; Colon; Disease Models, Animal; Feces; Interleukin-23; Mesalamine; Organ Size; Oxazolone; Random Allocation; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2009 |
[Paeoniflorin increases beta-defensin expression and attenuates lesion in the colonic mucosa from mice with oxazolone-induced colitis].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; beta-Defensins; Bridged-Ring Compounds; Colitis; Colon; Female; Glucosides; Interleukin-10; Interleukin-6; Intestinal Mucosa; Mesalamine; Mice; Mice, Inbred BALB C; Monoterpenes; Oxazolone; Paeonia; Random Allocation; RNA, Messenger | 2010 |
Bacterial immune interaction in experimental colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Colitis, Ulcerative; Colon; Disease Models, Animal; Female; Intestinal Mucosa; Mesalamine; Mice; Mice, Inbred BALB C; Microbiota; Occludin; Oxazolone; Polymorphism, Restriction Fragment Length; Severity of Illness Index; Toll-Like Receptor 2; Toll-Like Receptor 4; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2013 |
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Colitis, Ulcerative; Colon; Drug Therapy, Combination; Interleukin-10; Interleukin-13; Interleukin-6; Male; Mesalamine; Oxazolone; Rats; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha; Zonula Occludens-1 Protein | 2021 |
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis.
Topics: Anti-Inflammatory Agents; Atorvastatin; Colitis; Gene Expression; Humans; Interleukin-10; Interleukin-6; Mesalamine; Oxazolone | 2021 |